These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18332920)

  • 1. Hypotension during ERCP is common but not a risk factor for post-ERCP pancreatitis.
    Jacobson BC; Carr-Locke DL
    HPB (Oxford); 2001; 3(2):169-73. PubMed ID: 18332920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the 4-hour Post-ERCP amylase level to predict post-ERCP pancreatitis.
    Sutton VR; Hong MK; Thomas PR
    JOP; 2011 Jul; 12(4):372-6. PubMed ID: 21737899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
    Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
    Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.
    Testoni PA; Mariani A; Giussani A; Vailati C; Masci E; Macarri G; Ghezzo L; Familiari L; Giardullo N; Mutignani M; Lombardi G; Talamini G; Spadaccini A; Briglia R; Piazzi L;
    Am J Gastroenterol; 2010 Aug; 105(8):1753-61. PubMed ID: 20372116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
    Sherman S; Alazmi WM; Lehman GA; Geenen JE; Chuttani R; Kozarek RA; Welch WD; Souza S; Pribble J;
    Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):462-72. PubMed ID: 19231487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-ERCP pancreatitis rates do not differ between needle-knife and pull-type pancreatic sphincterotomy techniques: a multiendoscopist 13-year experience.
    Lawrence C; Romagnuolo J; Cotton PB; Payne KM; Hawes RH
    Gastrointest Endosc; 2009 Jun; 69(7):1271-5. PubMed ID: 19246037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.
    Rabenstein T; Fischer B; Wiessner V; Schmidt H; Radespiel-Tröger M; Hochberger J; Mühldorfer S; Nusko G; Messmann H; Schölmerich J; Schulz HJ; Schönekäs H; Hahn EG; Schneider HT
    Gastrointest Endosc; 2004 May; 59(6):606-13. PubMed ID: 15114301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification.
    Cheon YK; Cho KB; Watkins JL; McHenry L; Fogel EL; Sherman S; Lehman GA
    Gastrointest Endosc; 2007 Mar; 65(3):385-93. PubMed ID: 17321236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.
    Lee YK; Yang MJ; Kim SS; Noh CK; Cho HJ; Lim SG; Hwang JC; Yoo BM; Kim JH
    J Korean Med Sci; 2017 Nov; 32(11):1814-1819. PubMed ID: 28960034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotypical Metabolic Response to Endoscopic Retrograde Cholangiopancreatography Show Alterations in Pancreatic Function Regardless of Post-Procedure Pancreatitis.
    Lusczek ER; Colling K; Muratore S; Conwell D; Freeman M; Beilman G
    Clin Transl Gastroenterol; 2016 May; 7(5):e169. PubMed ID: 27148850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6, IL-10 and TNFα do not improve early detection of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: a prospective cohort study.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Mora J; Vidal S; Díez X; Torras X; Sainz S; Villanueva C; Farré A; Guarner-Argente C; Guarner C
    Sci Rep; 2016 Sep; 6():33492. PubMed ID: 27642079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic sphincterotomy by using pure-cut electrosurgical current and the risk of post-ERCP pancreatitis: a prospective randomized trial.
    Macintosh DG; Love J; Abraham NS
    Gastrointest Endosc; 2004 Oct; 60(4):551-6. PubMed ID: 15472677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication.
    Testoni PA
    JOP; 2002 Nov; 3(6):195-201. PubMed ID: 12432186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue ERCP and insertion of a small-caliber pancreatic stent to prevent the evolution of severe post-ERCP pancreatitis: a case-controlled series.
    Madácsy L; Kurucsai G; Joó I; Gódi S; Fejes R; Székely A
    Surg Endosc; 2009 Aug; 23(8):1887-93. PubMed ID: 19057957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis.
    Testoni PA; Bagnolo F
    Gastrointest Endosc; 2001 Jan; 53(1):33-9. PubMed ID: 11154486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are drugs a risk factor of post-ERCP pancreatitis?
    Perney P; Berthier E; Pageaux GP; Hillaire-Buys D; Roques V; Fabbro-Peray P; Melki M; Hanslik B; Bauret P; Larrey D; Blayac JP; Blanc F
    Gastrointest Endosc; 2003 Nov; 58(5):696-700. PubMed ID: 14595303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
    Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-hour post-ERCP amylase level: a useful indicator for early prediction of post-ERCP pancreatitis.
    Lv ZH; Kou DQ; Guo SB
    BMC Gastroenterol; 2020 Apr; 20(1):118. PubMed ID: 32306904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.